# DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation.

> **NCT03871296** · — · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 50 (estimated)

## Conditions studied

- Aging
- Stem Cell Transplant Complications

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03871296
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-10
- **Primary completion:** 2023-09-10
- **Final completion:** 2024-09-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-05-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03871296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03871296, "DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03871296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*